loadpatents
Patent applications and USPTO patent grants for Asculai; Samuel Simon.The latest application filed is for "formulations containing hyaluronic acid".
Patent | Date |
---|---|
Formulations containing hyaluronic acid Grant 6,218,373 - Falk , et al. April 17, 2 | 2001-04-17 |
Formulations containing hyaluronic acid Grant 6,140,312 - Falk , et al. October 31, 2 | 2000-10-31 |
Formulations containing hyaluronic acid Grant 6,136,793 - Falk , et al. October 24, 2 | 2000-10-24 |
Formulations containing hyaluronic acid Grant 6,114,314 - Falk , et al. September 5, 2 | 2000-09-05 |
Therapeutic methods using hyaluronic acid Grant 6,103,704 - Falk , et al. August 15, 2 | 2000-08-15 |
Use of hyaluronic acid and forms to prevent arterial restenosis Grant 6,022,866 - Falk , et al. February 8, 2 | 2000-02-08 |
Topical composition containing hyaluronic acid and nsaids Grant 6,017,900 - Falk , et al. January 25, 2 | 2000-01-25 |
Formulations containing hyaluronic acid Grant 5,990,096 - Asculai , et al. November 23, 1 | 1999-11-23 |
Formulations containing hyaluronic acid Grant 5,977,088 - Harper , et al. November 2, 1 | 1999-11-02 |
Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof Grant 5,972,906 - Asculai , et al. October 26, 1 | 1999-10-26 |
Topical composition containing hyaluronic acid and NSAIDS Grant 5,962,433 - Falk , et al. October 5, 1 | 1999-10-05 |
Formulations containing hyaluronic acid Grant 5,942,498 - Falk , et al. August 24, 1 | 1999-08-24 |
Treatment of disease and conditions Grant 5,914,322 - Falk , et al. June 22, 1 | 1999-06-22 |
Topical composition containing hyaluronic acid and NSAIDS Grant 5,910,489 - Falk , et al. June 8, 1 | 1999-06-08 |
Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID Grant 5,847,002 - Willoughby , et al. December 8, 1 | 1998-12-08 |
Hyaluronic acid and salts thereof inhibit arterial restenosis Grant 5,834,444 - Falk , et al. November 10, 1 | 1998-11-10 |
Topical composition containing hyaluronic acid and NSAIDS Grant 5,824,658 - Falk , et al. October 20, 1 | 1998-10-20 |
Clearing of atherosclerosis Grant 5,817,642 - Falk , et al. October 6, 1 | 1998-10-06 |
Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs Grant 5,792,753 - Falk , et al. August 11, 1 | 1998-08-11 |
Use of hyaluronic acid to repair ischemia reperfusion damage Grant 5,674,857 - Falk , et al. October 7, 1 | 1997-10-07 |
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs Grant 5,639,738 - Falk , et al. June 17, 1 | 1997-06-17 |
Nonionic surface active anti-herpes simplex viral agents Grant 4,020,183 - Asculai , et al. April 26, 1 | 1977-04-26 |
Serologic reaction method Grant 3,955,923 - Asculai May 11, 1 | 1976-05-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.